معرفی
Jenkins R E is a Lecturer of Microbiology and Infectious Disease at Swansea University's Swansea University Medical School within the Biomedical Sciences department (Faculty of Medicine, Health and Life Science). He has held this position since 2017, following a previous role as a Lecturer of Microbiology at Cardiff Metropolitan University (2013-2017). He also serves as an Editor for Microbiology Today (Microbiology Society, 2017-2022).
Research Focus
Jenkins' work spans microbiology, infectious diseases, and genotoxicology, with a focus on biomarkers for cancer detection (e.g., PIG-A mutations), nanomaterial toxicity mechanisms, and antimicrobial applications (e.g., Manuka honey for cystic fibrosis). Key projects include:
- Manuka Honey Research: Investigating its antibacterial efficacy and clinical potential in chronic cystic fibrosis infections (grants totaling £427,292 from 2018-2022).
- Nanomaterial Toxicity: Developing in vitro models (e.g., 3D liver spheroids) to assess genotoxicity and carcinogenicity of engineered nanoparticles.
- Cancer Biomarkers: Exploring blood-based biomarkers for early cancer detection and treatment response prediction.
Research Contributions
His articles emphasize genotoxicity testing methodologies, with recent work addressing:
- Mechanisms of DNA damage induced by pro-oxidant chemicals and nanomaterials.
- Development of standardized in vitro assays for carcinogenicity screening.
- Comparative studies on nanomaterial exposure effects in human vs. murine cell models.
Awards and Recognition
No explicit scientific awards are listed, though his sustained grant activity and editorial role highlight peer recognition.
Grants & Collaboration
Key grants include:
- Manuka Honey for Chronic Cystic Fibrosis Infection (£125,292, 2020-2022).
- Role of Manuka Honey in Cystic Fibrosis Management (£302,000, 2018-2021).
Collaborations involve interdisciplinary teams exploring nanosafety, cancer biology, and biomarker development.
